Biocon Ltd.
Research Biocon Ltd. (BIOCON.NS) on Bullrun: market cap INR 571.90B, P/E 103.3, dividend yield 0.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIOCON.NS
- ExchangeNSE
- CountryIndia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyINR
- Market capINR 571.90B
- P/E103.3
- Dividend yield0.1%
- Financial periodQ2 2026
- RevenueINR 42.92B
- Net incomeINR 1.41B
- Gross margin65.8%
Valuation Snapshot
latest market cap is INR 571.90B; P/E is 103.3; dividend yield is 0.1%.
Peer valuation comparison
Latest P/E is 103.31x versus a Healthcare sector median of 21.74x (375.1% above).
Latest dividend yield is 0.14% versus a Healthcare sector median of 2.4% (94.2% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 571.90B | 103.3 | 0.1% | 0.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.5 INR, yield 0.1%.
About Biocon Ltd.
Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biocon Ltd.'s market cap?
Biocon Ltd.'s market capitalization is INR 571.90B.
What is Biocon Ltd.'s P/E ratio?
Biocon Ltd.'s price-to-earnings (P/E) ratio is 103.3.
Does Biocon Ltd. pay a dividend?
Biocon Ltd. has a dividend yield of 0.1%.
What does Biocon Ltd. do?
Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments.